nodes	percent_of_prediction	percent_of_DWPC	metapath
Metolazone—Angiitis necrotising—Prednisone—Crohn's disease	0.0355	0.0355	CcSEcCtD
Metolazone—Skin necrosis—Mesalazine—Crohn's disease	0.0351	0.0351	CcSEcCtD
Metolazone—Vasculitis necrotising—Prednisone—Crohn's disease	0.031	0.031	CcSEcCtD
Metolazone—Abdominal bloating—Mesalazine—Crohn's disease	0.0258	0.0258	CcSEcCtD
Metolazone—Hyperuricaemia—Mercaptopurine—Crohn's disease	0.0244	0.0244	CcSEcCtD
Metolazone—Blood uric acid increased—Mercaptopurine—Crohn's disease	0.023	0.023	CcSEcCtD
Metolazone—Hypomagnesaemia—Mesalazine—Crohn's disease	0.0193	0.0193	CcSEcCtD
Metolazone—Throat sore—Mesalazine—Crohn's disease	0.017	0.017	CcSEcCtD
Metolazone—Oropharyngeal discomfort—Mesalazine—Crohn's disease	0.0169	0.0169	CcSEcCtD
Metolazone—Jaundice cholestatic—Azathioprine—Crohn's disease	0.0153	0.0153	CcSEcCtD
Metolazone—Jaundice cholestatic—Mesalazine—Crohn's disease	0.014	0.014	CcSEcCtD
Metolazone—Pancreatitis—Mercaptopurine—Crohn's disease	0.0139	0.0139	CcSEcCtD
Metolazone—Oropharyngeal pain—Mesalazine—Crohn's disease	0.0135	0.0135	CcSEcCtD
Metolazone—Skin exfoliation—Mesalazine—Crohn's disease	0.0117	0.0117	CcSEcCtD
Metolazone—Blood urea increased—Mesalazine—Crohn's disease	0.0116	0.0116	CcSEcCtD
Metolazone—Neuropathy—Mesalazine—Crohn's disease	0.0115	0.0115	CcSEcCtD
Metolazone—Photosensitivity—Mesalazine—Crohn's disease	0.0101	0.0101	CcSEcCtD
Metolazone—Anaemia—Mercaptopurine—Crohn's disease	0.00913	0.00913	CcSEcCtD
Metolazone—Lethargy—Mesalazine—Crohn's disease	0.00909	0.00909	CcSEcCtD
Metolazone—Leukopenia—Mercaptopurine—Crohn's disease	0.00884	0.00884	CcSEcCtD
Metolazone—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.0088	0.0088	CcSEcCtD
Metolazone—Arthralgia—Mercaptopurine—Crohn's disease	0.00841	0.00841	CcSEcCtD
Metolazone—Pancreatitis—Azathioprine—Crohn's disease	0.00828	0.00828	CcSEcCtD
Metolazone—Dry skin—Mesalazine—Crohn's disease	0.00816	0.00816	CcSEcCtD
Metolazone—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00813	0.00813	CcSEcCtD
Metolazone—Abdominal discomfort—Azathioprine—Crohn's disease	0.0081	0.0081	CcSEcCtD
Metolazone—Cramp muscle—Mesalazine—Crohn's disease	0.00802	0.00802	CcSEcCtD
Metolazone—Glycosuria—Prednisone—Crohn's disease	0.00801	0.00801	CcSEcCtD
Metolazone—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.0079	0.0079	CcSEcCtD
Metolazone—Petechiae—Prednisone—Crohn's disease	0.00789	0.00789	CcSEcCtD
Metolazone—Abdominal distension—Mesalazine—Crohn's disease	0.00775	0.00775	CcSEcCtD
Metolazone—Anorexia—Mercaptopurine—Crohn's disease	0.00769	0.00769	CcSEcCtD
Metolazone—Pancreatitis—Mesalazine—Crohn's disease	0.00755	0.00755	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00747	0.00747	CcSEcCtD
Metolazone—Abdominal discomfort—Mesalazine—Crohn's disease	0.00738	0.00738	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00735	0.00735	CcSEcCtD
Metolazone—Agranulocytosis—Azathioprine—Crohn's disease	0.00703	0.00703	CcSEcCtD
Metolazone—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00703	0.00703	CcSEcCtD
Metolazone—Decreased appetite—Mercaptopurine—Crohn's disease	0.00701	0.00701	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.0068	0.0068	CcSEcCtD
Metolazone—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00673	0.00673	CcSEcCtD
Metolazone—Epistaxis—Mesalazine—Crohn's disease	0.00647	0.00647	CcSEcCtD
Metolazone—Agranulocytosis—Mesalazine—Crohn's disease	0.0064	0.0064	CcSEcCtD
Metolazone—Erythema multiforme—Azathioprine—Crohn's disease	0.00639	0.00639	CcSEcCtD
Metolazone—Skin exfoliation—Prednisone—Crohn's disease	0.0062	0.0062	CcSEcCtD
Metolazone—Hepatitis—Mesalazine—Crohn's disease	0.00616	0.00616	CcSEcCtD
Metolazone—Neuropathy—Prednisone—Crohn's disease	0.00609	0.00609	CcSEcCtD
Metolazone—Chills—Azathioprine—Crohn's disease	0.00607	0.00607	CcSEcCtD
Metolazone—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00594	0.00594	CcSEcCtD
Metolazone—Erythema multiforme—Mesalazine—Crohn's disease	0.00582	0.00582	CcSEcCtD
Metolazone—Tinnitus—Mesalazine—Crohn's disease	0.00574	0.00574	CcSEcCtD
Metolazone—Chills—Mesalazine—Crohn's disease	0.00553	0.00553	CcSEcCtD
Metolazone—Diarrhoea—Mercaptopurine—Crohn's disease	0.00552	0.00552	CcSEcCtD
Metolazone—Ill-defined disorder—Azathioprine—Crohn's disease	0.00546	0.00546	CcSEcCtD
Metolazone—Anaemia—Azathioprine—Crohn's disease	0.00544	0.00544	CcSEcCtD
Metolazone—Malaise—Azathioprine—Crohn's disease	0.00531	0.00531	CcSEcCtD
Metolazone—Flatulence—Mesalazine—Crohn's disease	0.00528	0.00528	CcSEcCtD
Metolazone—Leukopenia—Azathioprine—Crohn's disease	0.00527	0.00527	CcSEcCtD
Metolazone—Vascular purpura—Prednisone—Crohn's disease	0.00527	0.00527	CcSEcCtD
Metolazone—Tension—Mesalazine—Crohn's disease	0.00526	0.00526	CcSEcCtD
Metolazone—Dysgeusia—Mesalazine—Crohn's disease	0.00525	0.00525	CcSEcCtD
Metolazone—Nervousness—Mesalazine—Crohn's disease	0.00521	0.00521	CcSEcCtD
Metolazone—Back pain—Mesalazine—Crohn's disease	0.00519	0.00519	CcSEcCtD
Metolazone—Muscle spasms—Mesalazine—Crohn's disease	0.00516	0.00516	CcSEcCtD
Metolazone—Vomiting—Mercaptopurine—Crohn's disease	0.00513	0.00513	CcSEcCtD
Metolazone—Rash—Mercaptopurine—Crohn's disease	0.00508	0.00508	CcSEcCtD
Metolazone—Dermatitis—Mercaptopurine—Crohn's disease	0.00508	0.00508	CcSEcCtD
Metolazone—Vision blurred—Mesalazine—Crohn's disease	0.00505	0.00505	CcSEcCtD
Metolazone—Arthralgia—Azathioprine—Crohn's disease	0.00501	0.00501	CcSEcCtD
Metolazone—Ill-defined disorder—Mesalazine—Crohn's disease	0.00498	0.00498	CcSEcCtD
Metolazone—Anaemia—Mesalazine—Crohn's disease	0.00496	0.00496	CcSEcCtD
Metolazone—Discomfort—Azathioprine—Crohn's disease	0.00495	0.00495	CcSEcCtD
Metolazone—Purpura—Prednisone—Crohn's disease	0.00489	0.00489	CcSEcCtD
Metolazone—Malaise—Mesalazine—Crohn's disease	0.00484	0.00484	CcSEcCtD
Metolazone—Vertigo—Mesalazine—Crohn's disease	0.00482	0.00482	CcSEcCtD
Metolazone—Syncope—Mesalazine—Crohn's disease	0.00481	0.00481	CcSEcCtD
Metolazone—Lethargy—Prednisone—Crohn's disease	0.00481	0.00481	CcSEcCtD
Metolazone—Leukopenia—Mesalazine—Crohn's disease	0.0048	0.0048	CcSEcCtD
Metolazone—Nausea—Mercaptopurine—Crohn's disease	0.00479	0.00479	CcSEcCtD
Metolazone—Palpitations—Mesalazine—Crohn's disease	0.00474	0.00474	CcSEcCtD
Metolazone—Loss of consciousness—Mesalazine—Crohn's disease	0.00471	0.00471	CcSEcCtD
Metolazone—Thrombocytopenia—Azathioprine—Crohn's disease	0.0047	0.0047	CcSEcCtD
Metolazone—Cough—Mesalazine—Crohn's disease	0.00468	0.00468	CcSEcCtD
Metolazone—Hypertension—Mesalazine—Crohn's disease	0.00463	0.00463	CcSEcCtD
Metolazone—Arthralgia—Mesalazine—Crohn's disease	0.00457	0.00457	CcSEcCtD
Metolazone—Chest pain—Mesalazine—Crohn's disease	0.00457	0.00457	CcSEcCtD
Metolazone—Anxiety—Mesalazine—Crohn's disease	0.00455	0.00455	CcSEcCtD
Metolazone—Discomfort—Mesalazine—Crohn's disease	0.00451	0.00451	CcSEcCtD
Metolazone—Dry mouth—Mesalazine—Crohn's disease	0.00447	0.00447	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00438	0.00438	CcSEcCtD
Metolazone—Dry skin—Prednisone—Crohn's disease	0.00432	0.00432	CcSEcCtD
Metolazone—Shock—Mesalazine—Crohn's disease	0.00431	0.00431	CcSEcCtD
Metolazone—Hypokalaemia—Prednisone—Crohn's disease	0.00429	0.00429	CcSEcCtD
Metolazone—Thrombocytopenia—Mesalazine—Crohn's disease	0.00429	0.00429	CcSEcCtD
Metolazone—Anorexia—Mesalazine—Crohn's disease	0.00417	0.00417	CcSEcCtD
Metolazone—Abdominal distension—Prednisone—Crohn's disease	0.0041	0.0041	CcSEcCtD
Metolazone—Pancreatitis—Prednisone—Crohn's disease	0.00399	0.00399	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00399	0.00399	CcSEcCtD
Metolazone—Feeling abnormal—Azathioprine—Crohn's disease	0.00396	0.00396	CcSEcCtD
Metolazone—Insomnia—Mesalazine—Crohn's disease	0.00396	0.00396	CcSEcCtD
Metolazone—Paraesthesia—Mesalazine—Crohn's disease	0.00393	0.00393	CcSEcCtD
Metolazone—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00393	0.00393	CcSEcCtD
Metolazone—Somnolence—Mesalazine—Crohn's disease	0.00389	0.00389	CcSEcCtD
Metolazone—Dyspepsia—Mesalazine—Crohn's disease	0.00385	0.00385	CcSEcCtD
Metolazone—Decreased appetite—Mesalazine—Crohn's disease	0.0038	0.0038	CcSEcCtD
Metolazone—Abdominal pain—Azathioprine—Crohn's disease	0.0038	0.0038	CcSEcCtD
Metolazone—Fatigue—Mesalazine—Crohn's disease	0.00377	0.00377	CcSEcCtD
Metolazone—Erectile dysfunction—Prednisone—Crohn's disease	0.00375	0.00375	CcSEcCtD
Metolazone—Pain—Mesalazine—Crohn's disease	0.00374	0.00374	CcSEcCtD
Metolazone—Constipation—Mesalazine—Crohn's disease	0.00374	0.00374	CcSEcCtD
Metolazone—Hyperglycaemia—Prednisone—Crohn's disease	0.00367	0.00367	CcSEcCtD
Metolazone—Feeling abnormal—Mesalazine—Crohn's disease	0.00361	0.00361	CcSEcCtD
Metolazone—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00358	0.00358	CcSEcCtD
Metolazone—Neuropathy peripheral—Prednisone—Crohn's disease	0.00356	0.00356	CcSEcCtD
Metolazone—Hypersensitivity—Azathioprine—Crohn's disease	0.00354	0.00354	CcSEcCtD
Metolazone—Urticaria—Mesalazine—Crohn's disease	0.00348	0.00348	CcSEcCtD
Metolazone—Abdominal pain—Mesalazine—Crohn's disease	0.00346	0.00346	CcSEcCtD
Metolazone—Diarrhoea—Azathioprine—Crohn's disease	0.00329	0.00329	CcSEcCtD
Metolazone—Hypersensitivity—Mesalazine—Crohn's disease	0.00322	0.00322	CcSEcCtD
Metolazone—Dizziness—Azathioprine—Crohn's disease	0.00318	0.00318	CcSEcCtD
Metolazone—Asthenia—Mesalazine—Crohn's disease	0.00314	0.00314	CcSEcCtD
Metolazone—Pruritus—Mesalazine—Crohn's disease	0.0031	0.0031	CcSEcCtD
Metolazone—Vomiting—Azathioprine—Crohn's disease	0.00306	0.00306	CcSEcCtD
Metolazone—Rash—Azathioprine—Crohn's disease	0.00303	0.00303	CcSEcCtD
Metolazone—Dermatitis—Azathioprine—Crohn's disease	0.00303	0.00303	CcSEcCtD
Metolazone—Headache—Azathioprine—Crohn's disease	0.00301	0.00301	CcSEcCtD
Metolazone—Diarrhoea—Mesalazine—Crohn's disease	0.00299	0.00299	CcSEcCtD
Metolazone—Dizziness—Mesalazine—Crohn's disease	0.00289	0.00289	CcSEcCtD
Metolazone—Nausea—Azathioprine—Crohn's disease	0.00285	0.00285	CcSEcCtD
Metolazone—Vomiting—Mesalazine—Crohn's disease	0.00278	0.00278	CcSEcCtD
Metolazone—Rash—Mesalazine—Crohn's disease	0.00276	0.00276	CcSEcCtD
Metolazone—Dermatitis—Mesalazine—Crohn's disease	0.00276	0.00276	CcSEcCtD
Metolazone—Headache—Mesalazine—Crohn's disease	0.00274	0.00274	CcSEcCtD
Metolazone—Vision blurred—Prednisone—Crohn's disease	0.00267	0.00267	CcSEcCtD
Metolazone—Ill-defined disorder—Prednisone—Crohn's disease	0.00263	0.00263	CcSEcCtD
Metolazone—Anaemia—Prednisone—Crohn's disease	0.00262	0.00262	CcSEcCtD
Metolazone—Agitation—Prednisone—Crohn's disease	0.00261	0.00261	CcSEcCtD
Metolazone—Nausea—Mesalazine—Crohn's disease	0.0026	0.0026	CcSEcCtD
Metolazone—Malaise—Prednisone—Crohn's disease	0.00256	0.00256	CcSEcCtD
Metolazone—Vertigo—Prednisone—Crohn's disease	0.00255	0.00255	CcSEcCtD
Metolazone—Syncope—Prednisone—Crohn's disease	0.00254	0.00254	CcSEcCtD
Metolazone—Loss of consciousness—Prednisone—Crohn's disease	0.00249	0.00249	CcSEcCtD
Metolazone—Hypertension—Prednisone—Crohn's disease	0.00245	0.00245	CcSEcCtD
Metolazone—Arthralgia—Prednisone—Crohn's disease	0.00242	0.00242	CcSEcCtD
Metolazone—Anxiety—Prednisone—Crohn's disease	0.00241	0.00241	CcSEcCtD
Metolazone—Discomfort—Prednisone—Crohn's disease	0.00239	0.00239	CcSEcCtD
Metolazone—Shock—Prednisone—Crohn's disease	0.00228	0.00228	CcSEcCtD
Metolazone—Anorexia—Prednisone—Crohn's disease	0.00221	0.00221	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00211	0.00211	CcSEcCtD
Metolazone—Insomnia—Prednisone—Crohn's disease	0.00209	0.00209	CcSEcCtD
Metolazone—Paraesthesia—Prednisone—Crohn's disease	0.00208	0.00208	CcSEcCtD
Metolazone—Dyspepsia—Prednisone—Crohn's disease	0.00204	0.00204	CcSEcCtD
Metolazone—Decreased appetite—Prednisone—Crohn's disease	0.00201	0.00201	CcSEcCtD
Metolazone—Fatigue—Prednisone—Crohn's disease	0.002	0.002	CcSEcCtD
Metolazone—Constipation—Prednisone—Crohn's disease	0.00198	0.00198	CcSEcCtD
Metolazone—Feeling abnormal—Prednisone—Crohn's disease	0.00191	0.00191	CcSEcCtD
Metolazone—Gastrointestinal pain—Prednisone—Crohn's disease	0.00189	0.00189	CcSEcCtD
Metolazone—Urticaria—Prednisone—Crohn's disease	0.00184	0.00184	CcSEcCtD
Metolazone—Abdominal pain—Prednisone—Crohn's disease	0.00183	0.00183	CcSEcCtD
Metolazone—Hypersensitivity—Prednisone—Crohn's disease	0.00171	0.00171	CcSEcCtD
Metolazone—Asthenia—Prednisone—Crohn's disease	0.00166	0.00166	CcSEcCtD
Metolazone—Pruritus—Prednisone—Crohn's disease	0.00164	0.00164	CcSEcCtD
Metolazone—Diarrhoea—Prednisone—Crohn's disease	0.00158	0.00158	CcSEcCtD
Metolazone—Dizziness—Prednisone—Crohn's disease	0.00153	0.00153	CcSEcCtD
Metolazone—Vomiting—Prednisone—Crohn's disease	0.00147	0.00147	CcSEcCtD
Metolazone—Rash—Prednisone—Crohn's disease	0.00146	0.00146	CcSEcCtD
Metolazone—Dermatitis—Prednisone—Crohn's disease	0.00146	0.00146	CcSEcCtD
Metolazone—Headache—Prednisone—Crohn's disease	0.00145	0.00145	CcSEcCtD
Metolazone—Nausea—Prednisone—Crohn's disease	0.00138	0.00138	CcSEcCtD
